Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma

Lenalidomide is an agent that has shown great activity in patients with multiple myeloma. However, studies have suggested that this drug negatively affects subsequent stem cell collection. To investigate whether lenalidomide impairs stem cell mobilization and collection, we reviewed data for patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Popat, Uday, Saliba, Rima, Thandi, Rupinderjit, Hosing, Chitra, Qazilbash, Muzaffar, Anderlini, Paolo, Shpall, Elizabeth, McMannis, John, Körbling, Martin, Alousi, Amin, Andersson, Borje, Nieto, Yago, Kebriaei, Partow, Khouri, Issa, de Lima, Marcos, Weber, Donna, Thomas, Sheeba, Wang, Michael, Jones, Roy, Champlin, Richard, Giralt, Sergio
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352933/
https://ncbi.nlm.nih.gov/pubmed/19450756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.02.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky